|
Type 2 diabetes
Citations 161-170 of 286 total displayed.
|
Past content
(since Dec 2000):
|
- Original Articles
Fructose Feeding Increases Insulin Resistance but Not Blood Pressure in Sprague-Dawley Rats
- Gerard D’Angelo, Ahmed A. Elmarakby, David M. Pollock, and David W. Stepp
Hypertension 2005;46:806-811; published online before print as doi:10.1161/01.HYP.0000182697.39687.34
[Abstract]
[Full text]
- Editorial Commentary
Overweight and Increased Cardiovascular Mortality. No French Paradox
- Frank B. Hu
Hypertension published September 12, 2005, doi:10.1161/01.HYP.0000184229.64767.a1
[Abstract]
- Scientific Contributions
Fructose Feeding Increases Insulin Resistance but Not Blood Pressure in Sprague-Dawley Rats
- Gerard D’Angelo, Ahmed A. Elmarakby, David M. Pollock, and David W. Stepp
Hypertension published September 12, 2005, doi:10.1161/01.HYP.0000182697.39687.34
[Abstract]
- Original Articles
PPAR -Activating Angiotensin Type-1 Receptor Blockers Induce Adiponectin
- Ronald Clasen, Michael Schupp, Anna Foryst-Ludwig, Christiane Sprang, Markus Clemenz, Maxim Krikov, Christa Thöne-Reineke, Thomas Unger, and Ulrich Kintscher
Hypertension 2005;46:137-143; published online before print as doi:10.1161/01.HYP.0000168046.19884.6a
[Abstract]
[Full text]
- Original Articles
Diabetic Neuropathy Is a More Important Determinant of Baroreflex Sensitivity Than Carotid Elasticity in Type 2 Diabetes
- Juan Ruiz, David Monbaron, Gianfranco Parati, Sophie Perret, Erik Haesler, Claude Danzeisen, and Daniel Hayoz
Hypertension 2005;46:162-167; published online before print as doi:10.1161/01.HYP.0000169053.14440.7d
[Abstract]
[Full text]
- Scientific Contributions
PPAR-Activating Angiotensin Type-1 Receptor Blockers Induce Adiponectin
- Ronald Clasen, Michael Schupp, Anna Foryst-Ludwig, Christiane Sprang, Markus Clemenz, Maxim Krikov, Christa Thöne-Reineke, Thomas Unger, and Ulrich Kintscher
Hypertension published June 6, 2005, doi:10.1161/01.HYP.0000168046.19884.6a
[Abstract]
- Original Articles
Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 Diabetes
- Kwang Kon Koh, Michael J. Quon, Seung Hwan Han, Jeong Yeal Ahn, Dong Kyu Jin, Hyung Sik Kim, Dae Sung Kim, and Eak Kyun Shin
Hypertension 2005;45:1088-1093; published online before print as doi:10.1161/01.HYP.0000166722.91714.ba
[Abstract]
[Full text]
- Scientific Contributions
Diabetic Neuropathy Is a More Important Determinant of Baroreflex Sensitivity Than Carotid Elasticity in Type 2 Diabetes
- Juan Ruiz, David Monbaron, Gianfranco Parati, Sophie Perret, Erik Haesler, Claude Danzeisen, and Daniel Hayoz
Hypertension published May 31, 2005, doi:10.1161/01.HYP.0000169053.14440.7d
[Abstract]
- Scientific Contributions
Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 Diabetes
- Kwang Kon Koh, Michael J. Quon, Seung Hwan Han, Jeong Yeal Ahn, Dong Kyu Jin, Hyung Sik Kim, Dae Sung Kim, and Eak Kyun Shin
Hypertension published May 9, 2005, doi:10.1161/01.HYP.0000166722.91714.ba
[Abstract]
- Brief Reviews
Mechanisms of Insulin Resistance in Humans and Possible Links With Inflammation
- David B. Savage, Kitt F. Petersen, and Gerald I. Shulman
Hypertension 2005;45:828-833; published online before print as doi:10.1161/01.HYP.0000163475.04421.e4
[Abstract]
[Full text]
|
|
